Related references
Note: Only part of the references are listed.Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
Wing-Yan Au et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia
Gerardo Quezada et al.
PEDIATRIC BLOOD & CANCER (2008)
Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia
Lan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement
Sabine Knipp et al.
LEUKEMIA RESEARCH (2007)
Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia
Ahmed Aribi et al.
CANCER (2007)
Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells
Jordy Leung et al.
BLOOD (2007)
Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR
Y-F Liu et al.
LEUKEMIA (2006)
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
E Estey et al.
BLOOD (2006)
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
V Mathews et al.
BLOOD (2006)
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
A Ghavamzadeh et al.
ANNALS OF ONCOLOGY (2006)
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia
PZ Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
ZX Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid
GJ Wang et al.
HEMATOLOGICAL ONCOLOGY (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation
A Grigg et al.
LEUKEMIA (2003)
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
All-trans retinoic acid in acute promyelocytic leukemia:: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
MS Tallman et al.
BLOOD (2002)
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia:: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
S Schnittger et al.
BLOOD (2002)
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia
F Patriarca et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
WY Au et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
YK Jing et al.
BLOOD (2001)
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
P Fenaux et al.
LEUKEMIA (2000)
Share Paper
